SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
April 14, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0000950170-23-012800.pdf 0000950170-23-012800.rtf 0000950170-23-012800.xls View HTML
March 1, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-029968.pdf 0001104659-21-029968.rtf 0001104659-21-029968.xls View HTML
February 11, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-22-020463.pdf 0001104659-22-020463.rtf 0001104659-22-020463.xls View HTML
February 14, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-22-040723.pdf 0001193125-22-040723.rtf 0001193125-22-040723.xls View HTML
February 14, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001193125-22-042110.pdf 0001193125-22-042110.rtf 0001193125-22-042110.xls View HTML
February 3, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001306550-23-006964.pdf 0001306550-23-006964.rtf View HTML
April 29, 2022	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-22-133777.pdf 0001193125-22-133777.rtf 0001193125-22-133777.xls View HTML
April 28, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0000950170-23-015491.pdf 0000950170-23-015491.rtf View HTML
January 13, 2017	D/A	Amend: Notice of Exempt Offering of Securities	0001656536-17-000002.pdf 0001656536-17-000002.rtf View HTML
January 28, 2021	S-1/A	Amended Registration statement for face-amount certificate companies	0001193125-21-020896.pdf 0001193125-21-020896.rtf 0001193125-21-020896.xls View HTML

Data provided by Kaleidoscope.

Main Corporate Nav